Additionally, the expression of CFB is downregulated in clinical samples of lung adenocarcinoma (LUAD), while its overexpression can inhibit tumor growth, cell proliferation, and migration, and promote cell apoptosis and cell cycle arrest. Here, CFB is linked to lung adenocarcinoma.